Literature DB >> 22503965

Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells.

Dorit Elberg1, Martin A Turman, Nick Pullen, Gerard Elberg.   

Abstract

Previously, we demonstrated that prostaglandin E(2) (PGE(2)) induced cAMP and cyst formation through PGE(2) receptor-2 (EP2) activity in human autosomal-dominant polycystic kidney disease (ADPKD) epithelial cells. In this study, we determined the role of EP2 and EP4 receptors in mediating PGE(2) stimulation of cAMP signaling and cystogenesis in mouse renal epithelial cells using the inner medullary collecting duct-3 (IMCD-3) cell line. In contrast to human ADPKD cells, using novel EP2 and EP4 antagonists, we found that IMCD-3 cells expressed functional EP4 but not EP2, which stimulated cAMP formation and led to cyst formation in 3D culture system. The involvement of EP4 receptors in IMCD-3 cells was further supported by the specific effect of EP4 siRNA that inhibited PGE(2)-induced cystogenesis. We also observed different cellular localization of EP2 or EP4 receptors in IMCD-3 transfected cells. Collectively, our results suggest an important role of different expression of EP2 or EP4 receptors in the regulation of cystogenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503965     DOI: 10.1016/j.prostaglandins.2012.03.005

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  8 in total

1.  Renal cyclooxygenase products are higher and lipoxygenase products are lower in early disease in the pcy mouse model of adolescent nephronophthisis.

Authors:  Tamio Yamaguchi; Clara Lysecki; Ashleigh Reid; Shizuko Nagao; Harold M Aukema
Journal:  Lipids       Date:  2013-11-01       Impact factor: 1.880

2.  Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2WS25/- mouse model of autosomal dominant polycystic kidney disease.

Authors:  Md Monirujjaman; Harold M Aukema
Journal:  J Nephrol       Date:  2019-01-22       Impact factor: 3.902

3.  Soy Protein Alleviates Hypertension and Fish Oil Improves Diastolic Heart Function in the Han:SPRD-Cy Rat Model of Cystic Kidney Disease.

Authors:  Naser H M Ibrahim; Sijo J Thandapilly; Yong Jia; Thomas Netticadan; Harold Aukema
Journal:  Lipids       Date:  2015-12-01       Impact factor: 1.880

4.  Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Joseph Zimpelmann; Andrew J Karam; Jean-Francois Thibodeau; Dylan Burger; Kevin D Burns; Chris Rj Kennedy; Richard L Hébert
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

5.  Prostaglandin E2 induces chloride secretion through crosstalk between cAMP and calcium signaling in mouse inner medullary collecting duct cells.

Authors:  Madhumitha Rajagopal; Sheela V Thomas; Paru P Kathpalia; Yu Chen; Alan C Pao
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-27       Impact factor: 4.249

Review 6.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

7.  Antagonism of the prostaglandin E2 EP1 receptor in MDCK cells increases growth through activation of Akt and the epidermal growth factor receptor.

Authors:  Mary Taub; Robert Parker; Paremala Mathivanan; Muhamad Asnawi Mohd Ariff; Trina Rudra
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-09

8.  A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation.

Authors:  Jan N Hansen; Fabian Kaiser; Philipp Leyendecker; Birthe Stüven; Jens-Henning Krause; Fatemeh Derakhshandeh; Jaazba Irfan; Tommy J Sroka; Kenley M Preval; Paurav B Desai; Michael Kraut; Heidi Theis; Anna-Dorothee Drews; Elena De-Domenico; Kristian Händler; Gregory J Pazour; David J P Henderson; David U Mick; Dagmar Wachten
Journal:  EMBO Rep       Date:  2022-06-13       Impact factor: 9.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.